H.R. 608 (108th): Pharmaceutical Products Price Equity Act

Feb 05, 2003 (108th Congress, 2003–2004)
Died (Referred to Committee)
Major Owens
Representative for New York's 11th congressional district
Read Text »
Last Updated
Feb 05, 2003
13 pages
Related Bills
H.R. 1574 (107th) was a previous version of this bill.

Referred to Committee
Last Action: Apr 24, 2001

H.R. 4850 (109th) was a re-introduction of this bill in a later Congress.

Referred to Committee
Last Action: Mar 02, 2006


This bill was introduced on February 5, 2003, in a previous session of Congress, but was not enacted.

Introduced Feb 05, 2003
Referred to Committee Feb 05, 2003
Full Title

To provide for prices of pharmaceutical products that are fair to the producer and the consumer, and for other purposes.


No summaries available.


House Energy and Commerce

Commerce, Manufacturing, and Trade

House Judiciary

Courts, Intellectual Property, and the Internet

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements, to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 608 (108th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus